FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-alectinib-adjuvant-treatment-alk-positive-non-small-cell-lung-cancer